Cancer screenings have been viewed as a life-saving early detection and prevention strategy against the disease.
However, findings published in a new meta-analysis examining more than 2.1 million people suggest that early testing may not always deliver increases in life expectancy, leading scientists to question the value of these screenings.
Sigmoidoscopy Leads in Life Expectancy
After comparing six tests commonly used to detect breast, lung, prostate, and colon cancer, only sigmoidoscopy—a medical procedure used to look for abnormalities inside the colon—showed a significant impact on life gains of 110 days.
Mary Gillis
Author
Mary Elizabeth Gillis is a health reporter and cardiopulmonary specialist with over a decade of experience. After graduating with her doctorate in applied physiology, she earned a master of science degree in journalism from Columbia University.
